320 related articles for article (PubMed ID: 33429291)
1. The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice.
van der Weyden L; Jonkers J; Adams DJ
Curr Opin Genet Dev; 2021 Feb; 66():57-62. PubMed ID: 33429291
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
Jacinto FV; Link W; Ferreira BI
J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 for cancer research and therapy.
Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
[TBL] [Abstract][Full Text] [Related]
7. Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice.
Bu W; Creighton CJ; Heavener KS; Gutierrez C; Dou Y; Ku AT; Zhang Y; Jiang W; Urrutia J; Jiang W; Yue F; Jia L; Ibrahim AA; Zhang B; Huang S; Li Y
Sci Adv; 2023 May; 9(19):eade0059. PubMed ID: 37172086
[TBL] [Abstract][Full Text] [Related]
8. CRISPR base editors: genome editing without double-stranded breaks.
Eid A; Alshareef S; Mahfouz MM
Biochem J; 2018 Jun; 475(11):1955-1964. PubMed ID: 29891532
[TBL] [Abstract][Full Text] [Related]
9. The CRISPR/Cas9 system and its applications in crop genome editing.
Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP
Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772
[TBL] [Abstract][Full Text] [Related]
10. Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy.
Sarkar E; Khan A
Cancer Treat Res Commun; 2021; 27():100289. PubMed ID: 33667951
[TBL] [Abstract][Full Text] [Related]
11. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
12. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
Prykhozhij SV; Caceres L; Berman JN
Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
[TBL] [Abstract][Full Text] [Related]
13. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
Ebrahimi V; Hashemi A
Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-Based Genome Editing Toolbox for Arabidopsis thaliana.
Miki D; Zinta G; Zhang W; Peng F; Feng Z; Zhu JK
Methods Mol Biol; 2021; 2200():121-146. PubMed ID: 33175375
[TBL] [Abstract][Full Text] [Related]
16. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
Potts MA; McDonald JA; Sutherland KD; Herold MJ
Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.
Cai W; Luo T; Mao L; Wang M
Angew Chem Int Ed Engl; 2021 Apr; 60(16):8596-8606. PubMed ID: 32385892
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
Muramoto T; Iriki H; Watanabe J; Kawata T
Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
[TBL] [Abstract][Full Text] [Related]
19. Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer.
Jiang C; Lin X; Zhao Z
Trends Mol Med; 2019 Nov; 25(11):1039-1049. PubMed ID: 31422862
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 gene editing in a chicken model: current approaches and applications.
Chojnacka-Puchta L; Sawicka D
J Appl Genet; 2020 May; 61(2):221-229. PubMed ID: 31925767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]